FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136372164> ?p ?o ?g. }

• W3136372164 endingPage "341" @default.
• W3136372164 startingPage "328" @default.
• W3136372164 abstract "Clinical studies have reported that miRNAs abnormal expression are associated with the generation of cisplatin-resistant to osteosarcoma. Our previous research found that miR-203 is downregulated in osteosarcoma cells and overexpressed miR-203 exerts antitumor properties on osteosarcoma cells. However, the role and mechanism of miR-203 in regulating the sensitivity of cisplatin in osteosarcoma cells remains unclear. This study aimed to investigate the effects of miR-203 in cisplatin therapy for osteosarcoma cells in vitro and determined the underlying mechanism. In this study, we found that miR-203 was significantly upregulated in osteosarcoma cells after exposure to cisplatin. miR-203 knockdown reduced the sensitivity of osteosarcoma cells to cisplatin by suppressing cell apoptosis, cell cycle arrest, and inducing invasion. Meanwhile, we found that miR-203 knockdown reduces the therapeutic sensitivity of osteosarcoma cells by upregulating RUNX2. Moreover, we found that RUNX2 silencing sensitizes osteosarcoma cells to chemotherapy treatment of cisplatin. In summary, our findings demonstrated that miR-203 knockdown reduces cisplatin chemo-sensitivity to osteosarcoma cells in vitro by targeting RUNX2, and speculated that miR-203 may be a target for drug resistance of osteosarcoma to cisplatin." @default.
• W3136372164 created "2021-03-29" @default.
• W3136372164 creator A5006117401 @default.
• W3136372164 creator A5036773734 @default.
• W3136372164 creator A5040548313 @default.
• W3136372164 creator A5061819132 @default.
• W3136372164 creator A5065160830 @default.
• W3136372164 creator A5078137698 @default.
• W3136372164 creator A5082585878 @default.
• W3136372164 creator A5090135566 @default.
• W3136372164 date "2021-03-25" @default.
• W3136372164 modified "2023-09-27" @default.
• W3136372164 title "Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS <i>in vitro</i> by targeting RUNX2" @default.
• W3136372164 cites W1168050307 @default.
• W3136372164 cites W1550409905 @default.
• W3136372164 cites W1951136951 @default.
• W3136372164 cites W1988325237 @default.
• W3136372164 cites W1990868443 @default.
• W3136372164 cites W2005087448 @default.
• W3136372164 cites W2009366335 @default.
• W3136372164 cites W2016964783 @default.
• W3136372164 cites W2017422522 @default.
• W3136372164 cites W2019156893 @default.
• W3136372164 cites W2050126271 @default.
• W3136372164 cites W2080073306 @default.
• W3136372164 cites W2116799486 @default.
• W3136372164 cites W2131112855 @default.
• W3136372164 cites W2139619092 @default.
• W3136372164 cites W2141037581 @default.
• W3136372164 cites W2142484843 @default.
• W3136372164 cites W2149177655 @default.
• W3136372164 cites W2162674813 @default.
• W3136372164 cites W2163169932 @default.
• W3136372164 cites W2176135723 @default.
• W3136372164 cites W2233647023 @default.
• W3136372164 cites W2235951706 @default.
• W3136372164 cites W2274595380 @default.
• W3136372164 cites W2292491300 @default.
• W3136372164 cites W2321411011 @default.
• W3136372164 cites W2331950914 @default.
• W3136372164 cites W2346343319 @default.
• W3136372164 cites W2505113069 @default.
• W3136372164 cites W2534236232 @default.
• W3136372164 cites W2564446381 @default.
• W3136372164 cites W2596148229 @default.
• W3136372164 cites W2606385901 @default.
• W3136372164 cites W2608767447 @default.
• W3136372164 cites W2615964030 @default.
• W3136372164 cites W2619218883 @default.
• W3136372164 cites W2754595480 @default.
• W3136372164 cites W2755780364 @default.
• W3136372164 cites W2762383696 @default.
• W3136372164 cites W2763342153 @default.
• W3136372164 cites W2769283156 @default.
• W3136372164 cites W2891669485 @default.
• W3136372164 cites W2895259727 @default.
• W3136372164 cites W2897857928 @default.
• W3136372164 cites W2897912817 @default.
• W3136372164 cites W2897926526 @default.
• W3136372164 cites W2914532002 @default.
• W3136372164 cites W2914986578 @default.
• W3136372164 cites W2952135531 @default.
• W3136372164 cites W2957166771 @default.
• W3136372164 cites W2965922802 @default.
• W3136372164 cites W2981442203 @default.
• W3136372164 cites W2990491574 @default.
• W3136372164 cites W2994950253 @default.
• W3136372164 cites W3000145158 @default.
• W3136372164 cites W3011748021 @default.
• W3136372164 cites W3087198975 @default.
• W3136372164 doi "https://doi.org/10.1080/1120009x.2021.1899441" @default.
• W3136372164 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33764270" @default.
• W3136372164 hasPublicationYear "2021" @default.
• W3136372164 type Work @default.
• W3136372164 sameAs 3136372164 @default.
• W3136372164 citedByCount "5" @default.
• W3136372164 countsByYear W31363721642022 @default.
• W3136372164 countsByYear W31363721642023 @default.
• W3136372164 crossrefType "journal-article" @default.
• W3136372164 hasAuthorship W3136372164A5006117401 @default.
• W3136372164 hasAuthorship W3136372164A5036773734 @default.
• W3136372164 hasAuthorship W3136372164A5040548313 @default.
• W3136372164 hasAuthorship W3136372164A5061819132 @default.
• W3136372164 hasAuthorship W3136372164A5065160830 @default.
• W3136372164 hasAuthorship W3136372164A5078137698 @default.
• W3136372164 hasAuthorship W3136372164A5082585878 @default.
• W3136372164 hasAuthorship W3136372164A5090135566 @default.
• W3136372164 hasConcept C104317684 @default.
• W3136372164 hasConcept C119056186 @default.
• W3136372164 hasConcept C126322002 @default.
• W3136372164 hasConcept C145059251 @default.
• W3136372164 hasConcept C173396325 @default.
• W3136372164 hasConcept C185592680 @default.
• W3136372164 hasConcept C190283241 @default.
• W3136372164 hasConcept C2776694085 @default.
• W3136372164 hasConcept C2777760704 @default.
• W3136372164 hasConcept C2778239845 @default.
• W3136372164 hasConcept C502942594 @default.

• next